Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic effect of vasoactive intestinal peptide in collagen-induced arthritis.

× No keyword cloud information.

11 in total

Review 1. Analysing the effect of novel therapies on cytokine expression in experimental arthritis.

Authors: Richard O Williams; Julia J Inglis; Egle Simelyte; Gabriel Criado; Percy F Sumariwalla
Journal: Int J Exp Pathol Date: 2005-10 Impact factor: 1.925

2. Protected graft copolymer excipient leads to a higher acute maximum tolerated dose and extends residence time of vasoactive intestinal Peptide significantly better than sterically stabilized micelles.

Authors: Sandra Reichstetter; Gerardo M Castillo; Israel Rubinstein; Akiko Nishimoto-Ashfield; Manshun Lai; Cynthia C Jones; Aryamitra A Banerjee; Aryamitra Banjeree; Alex Lyubimov; Duane C Bloedow; Alexei Bogdanov; Elijah M Bolotin
Journal: Pharm Res Date: 2012-12-07 Impact factor: 4.200

3. Vasoactive intestinal peptide signaling axis in human leukemia.

Authors: Glenn Paul Dorsam; Keith Benton; Jarrett Failing; Sandeep Batra
Journal: World J Biol Chem Date: 2011-06-26

4. Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis.

Authors: R Newman; N Cuan; T Hampartzoumian; S J Connor; A R Lloyd; M C Grimm
Journal: Clin Exp Immunol Date: 2005-03 Impact factor: 4.330

5. Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.

Authors: B M Lodde; F Mineshiba; J Wang; A P Cotrim; S Afione; P P Tak; B J Baum
Journal: Ann Rheum Dis Date: 2005-06-23 Impact factor: 19.103

6. Impact of cAMP on the T-cell response to type II collagen.

Authors: Patricia Ozegbe; Andrew D Foey; Salman Ahmed; Richard O Williams
Journal: Immunology Date: 2004-01 Impact factor: 7.397

Review 7. Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.

Authors: Elena Gonzalez-Rey; Per Anderson; Mario Delgado
Journal: Ann Rheum Dis Date: 2007-11 Impact factor: 19.103

8. Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis.

Authors: Ola Grimsholm; Solbritt Rantapää-Dahlqvist; Sture Forsgren
Journal: Arthritis Res Ther Date: 2005-02-07 Impact factor: 5.156

9. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.

Authors: Andrew D Foey; Sarah Field; Salman Ahmed; Abhilash Jain; Marc Feldmann; Fionula M Brennan; Richard Williams
Journal: Arthritis Res Ther Date: 2003-09-03 Impact factor: 5.156

10. Vasoactive intestinal peptide alleviates osteoarthritis effectively via inhibiting NF-κB signaling pathway.

Authors: Yaozhong Liang; Shu Chen; Yuhao Yang; Chunhai Lan; Guowei Zhang; Zhisheng Ji; Hongsheng Lin
Journal: J Biomed Sci Date: 2018-03-14 Impact factor: 8.410